Hepion Pharmaceuticals (HEPA) Financial Statements

Hepion Pharmaceuticals's market cap is currently $755.32K. The company's EPS TTM is $-109.303; its P/E ratio is >-0.01; Hepion Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.